Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

David Riches to Disease Progression

This is a "connection" page, showing publications David Riches has written about Disease Progression.

 
Connection Strength
 
 
 
0.153
 
  1. Redente EF, Black BP, Backos DS, Bahadur AN, Humphries SM, Lynch DA, Tuder RM, Zemans RL, Riches DWH. Persistent, Progressive Pulmonary Fibrosis and Epithelial Remodeling in Mice. Am J Respir Cell Mol Biol. 2021 06; 64(6):669-676.
    View in: PubMed
    Score: 0.098
  2. Freeberg MAT, Redente EF, Perelas A, Riches DWH, Schwartz DA, Sime PJ. Pulmonary Fibrosis-Focusing on the Future: Aspen Lung Conference 2024 Summary. Am J Respir Cell Mol Biol. 2025 11; 73(5):653-667.
    View in: PubMed
    Score: 0.033
  3. Wollin L, Distler JHW, Redente EF, Riches DWH, Stowasser S, Schlenker-Herceg R, Maher TM, Kolb M. Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases. Eur Respir J. 2019 09; 54(3).
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)